Impact of renal cadaveric transplantation on survival in end-stage renal failure: Evidence for reduced mortality risk compared with hemodialysis during long-term follow-up

Journal of the American Society of Nephrology

Volumn 9, Issue 11, 1998, Pages 2135-2141

  Schnuelle, Peter ^a   Lorenz, Dietmar ^b   Trede, Michael ^b   Van Der Woude, Fokko J ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; T LYMPHOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GRAFT FAILURE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031728260     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Agoda LY, Eggers PW: Renal replacement therapy in the United States: Data from the United States Renal Data System. Am J Kidney Dis 25: 119-133, 1995
2. Disney APS, for the Australia and New Zealand Dialysis and Transplant Registry: Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: Report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry. Am J Kidney Dis 25: 165-175, 1995
3. Teraoka S, Toma H, Nihei H, Ota K, Babazono T, Ishikawa I, Shinoda A, Maeda K, Koshikawa S, Takahashi T, Sonoda T: Current status of renal replacement therapy in Japan. Am J Kidney Dis 25: 151-164, 1995
4. Mallick NP, Jones E, Selwood N: The European (European Dialysis and Transplantation Association-European Renal Association) Registry. Am J Kidney Dis 25: 176-187, 1995
5. Opelz G: Collaborative transplant study: 10 year report. Transplant Proc 24: 2342-2355, 1992
6. Russel JD, Beecroft ML, Ludwin D, Churchill DN: The quality of life in renal transplantation: A prospective study. Transplantation 54: 656-660, 1992
7. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, Muirhead N: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50: 235-242, 1996
8. Vollmer WM, Wahl PW, Blagg CR: Survival with dialysis and transplantation in patients with end-stage renal disease. N Engl J Med 308: 1553-1558, 1983
9. Hutchinson TA, Thomas DC, Lemieux JC, Harvey CE: Prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 26: 44-51, 1984
10. Garcia-Garcia G, Deddens JA, D'Achiardi-Rey R, First MR, Samuels SJ, Kant KS, Pollak VE: Results of treatment in patients with end-stage renal disease: A multi-variate analysis of risk factors and survival in 341 successive patients. Am J Kidney Dis 5: 10-18, 1985
11. Burton PR, Walls J: Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, haemodialysis and renal transplantation. Lancet 1: 1115-1119, 1987
12. Schaubel D, Desmeules M, Mao Y, Jeffery J, Fenton S: Survival experience among elderly end-stage renal disease patients: A controlled comparison of transplantation and dialysis. Transplantation 60: 1389-1394, 1995
13. Shiohira Y, Iseki K, Kowatari T, Uehara H, Yoshihara K, Nishime K, Arakaki Y, Koyama Y, Ogawa Y, Fukiyama K: A community-based evaluation of the effect of renal transplantation on survival in patients with renal replacement therapy. Nippon Jinzo Gakkai Shi 38: 449-454, 1996
14. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K: Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 270: 1339-1343, 1993
15. Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L, Berling DP: Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis 24: 59-64, 1994
16. Gaylin DS, Held PJ, Port FK, Hunsicker LG, Wolfe RA, Kahan BD, Jones CA, Agodoa LY: The impact of comorbid and socio-demographic factors on access to renal transplantation. JAMA 269: 603-608, 1993
17. Held PJ, Blagg CR, Liska DW, Port FK, Hakim R, Levin N: The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int 38: 16-21, 1992
18. Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK: ESDR patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50: 1013-1018, 1996
19. Khan ICH, Campbell MK, Cantarovich D, Catto GR, Delcroix C, Edward N, Fontenaille C, Fleming LW, Gerlag PG, van Hamersvelt HW, Henderson IS, Koene RA, Papadimitrou M, Ritz E, Russell IT, Stier E, Tsakiris D, MacLeod AM: Survival on renal replacement therapy in Europe: Is there a "centre effect"? Nephrol Dial Transplant 11: 300-307, 1996
20. Wujciak T, Opelz G: A proposal for improved cadaver kidney allocation. Transplantation 56: 1513-1517, 1993
21. Cox DR: Regression models and life-tables. J Stat Soc 34: 187-220, 1972
22. Crowley J, Hu M: Covariance analysis of heart transplant survival data. J Am Stat Assoc 72: 27-36, 1977
23. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data, New York, John Wiley & Sons, 1980, pp 231-232
24. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttman RD: Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60: 908-914, 1995
25. Surdacki A, Wieczorek-Surdacka E, Sulowicz W, Dubiel JS: Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy. Nephrol Dial Transplant 10: 1218-1223, 1995
26. Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis JJ: The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 29: 608-614, 1997
27. Fauchald P, Albrechtsen D, Leivestad T, Berg KJ, Talseth T, Flatmark A: Renal replacement therapy in elderly patients. Transplant Int 1: 131-134, 1988
28. Schulak JA, Mayes JT, Johnston KH, Hricik DE: Kidney transplantation in patients aged sixty years and older. Surgery 108: 726-731, 1990
29. Morris GE, Jamieson NV, Small J, Evans DB, Calne R: Cadaveric renal transplantation in elderly recipients: Is it worthwhile? Nephrol Dial Transplant 6: 887-892, 1991
30. Benedetti E, Matas AJ, Hakim N, Fasola C, Gillingham K, McHugh L, Najarian JS: Renal transplantation for patients 60 years and older: A single-institution experience. Ann Surg 220: 445-458, 1994
31. Cantarovich D, Baastard R, Baranger T, Tirouvanziam A, Le Sant JN, Hourmant M, Dantal J, Soulillou JP: Cadaveric renal transplantation after 60 years of age: A single center experience. Transplant Int 7: 33-38, 1994
32. Cecka JM, Terasaki PI: Scientific Renal Transplant Registry: United Network for Organ Sharing. Clin Transpl 1-18, 1994
33. Hodge EE, Goormastic M, Straffon RA, Novick AC, Streem SB, Goldfarb DA. Dennis VW, Nally JV, Braun WE, Cook DJ: Changing demographics in renal transplant recipients: The 30 year Cleveland Clinic experience. Clin Transpl 221-231, 1995
34. Bloembergen WE, Stannard DC, Port FK, Wolfe RA, Pugh JA, Jones CA, Greer JW, Golper TA, Held PJ: Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 50: 557-565, 1996
35. Eliahou HE, Iaina A, Reisin E, Shapira J: Probability of survival in hypertensive and normotensive patients on maintenance hemodialysis. Isr J Med Sci 13: 33-38, 1977
36. Salem MM, Bower J: Hypertension in the hemodialysis population: Any relation to one-year survival? Am J Kidney Dis 28: 737-740, 1996
37. Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA: Patient survival after renal transplantation: More than 25 years follow-up. Nephrol Dial Transplant 12: 1672-1679, 1997
38. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d'Avolio G, Gelatti U: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: A longitudinal study. Nephrol Dial Transplant 10: 2295-2305, 1995
39. Pichlmayr R, for the European Mycophenolate Mofetil Cooperative Study Group: Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 345: 1321-1325, 1995
40. Sollinger HW, for the US Renal Transplant Mycophenolate Mofetil Study Group: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60: 225-232, 1995
41. Keown PA, for the Tricontinental Mycophenolate Mofetil Renal Transplant Study Group: A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61: 1029-1037, 1996
42. Halloran P, Mathew T, Tomlanovich S, Groth L, Hooftman L, Barker C, for the International Mycophenolate Mofetil Renal Transplant Study Groups: Mycophenolate mofetil in renal allograft recipients. Transplantation 63: 39-47, 1997
43. Diethelm AG, Deierhoi MH, Hudson SL, Laskow DA, Julian BA, Gaston RS, Bynon JS, Curtis JJ: Progress in renal transplantation: A single center study of 3359 patients over 25 years. Ann Surg 221: 446-458, 1995